Annals of Pediatric Endocrinology & Metabolism10.6065/apem.2142046.0232021263199-204Efficacy and adverse events related to the initial dose of methimazole in children and adolescents with Graves’ diseaseHyun Gyung Lee, Eun Mi Yang, Chan Jong Kim,,
Thyroid10.1089/thy.2014.0084201525143-50Comparison of Efficacy and Adverse Effects Between Methimazole 15 mg+Inorganic Iodine 38 mg/Day and Methimazole 30 mg/Day as Initial Therapy for Graves' Disease Patients with Moderate to Severe HyperthyroidismShotaro Sato, Jaeduk Yoshimura Noh, Shiori Sato, Miho Suzuki, Shigemitsu Yasuda, Masako Matsumoto, Yo Kunii, Koji Mukasa, Kiminori Sugino, Koichi Ito, Shigenobu Nagataki, Matsuo Taniyama,
International Journal of Pediatric Endocrinology10.1186/1687-9856-2013-s1-p13920132013S1Adverse events related with propylthiouracil therapy of Graves’ Disease in children at Cipto Mangunkusumo Hospital JakartaNovina Andriana, Aman B Pulungan, Bambang Tridjaja,,
Clinical Endocrinology10.1046/j.1365-2265.1998.00554.x1998494451-457Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective studyGeorg Benker, Dankwart Reinwein, Georg Kahaly, Lennart Tegler, W. Donald Alexander, Johanes Faßbinder, Herbert Hirche,,,
Journal of the Endocrine Society10.1210/jendso/bvab015202154Erratum to: Serum T3 Level and Duration of Minimum Maintenance Dose Therapy Predict Relapse in Methimazole-Treated Graves Disease,
CNS Neuroscience & Therapeutics10.1111/j.1755-5949.2009.00106.x201016283-90Neuroendocrine-Related Adverse Events Associated with Antidepressant Treatment in Children and AdolescentsJeanette M. Jerrell,
Annals of Oncology10.1093/annonc/mdw390.55201627vi515Immune-related and adverse events following low versus high initial dose of Viscum album L. in cancer patientsM.L. Steele, F. Schad,,
Journal of Medical Case Reports10.1186/s13256-021-02788-42021151Efficacy of low-dose methimazole in control of multiple relapses of Graves’ hyperthyroidism: a case reportFereidoun Azizi, Atieh Amouzegar, Hengameh Abdi,,
Thyroid10.1089/thy.2008.03642009196559-563Methimazole-Induced Agranulocytosis in Patients with Graves' Disease Is More Frequent with an Initial Dose of 30 mg Daily than with 15 mg DailyKazuna Takata, Sumihisa Kubota, Shuji Fukata, Takumi Kudo, Eijun Nishihara, Mitsuru Ito, Nobuyuki Amino, Akira Miyauchi
Annals of Pediatric Endocrinology & Metabolism10.6065/apem.2016.21.2.70201621270Predictive factors for early response to methimazole in children and adolescents with Graves disease: a single-institute study between 1993 and 2013Sun Mi Hwang, Min Sun Kim, Dae-Yeol Lee